Sanjay Kumar Jain, M.D., M.B.B.S, director, Center for Infection and Inflammation Imaging Research and professor of pediatrics, Johns Hopkins University
Vanessa Ruta, Ph.D., Gabrielle H. Reem and Herbert J. Kayden Associate Associate Professor and head, Laboratory of Neurophysiology and Behavior, The Rockefeller University
Anne Brunet, Ph.D., Michele and Timothy Barakett Endowed Professor, Co-director of the Paul F. Glenn Laboratories for the Biology of Aging, Stanford University
Sanjay Kumar Jain, M.D., M.B.B.S, director, Center for Infection and Inflammation Imaging Research and professor of pediatrics, Johns Hopkins University
Vanessa Ruta, Ph.D., Gabrielle H. Reem and Herbert J. Kayden Associate Associate Professor and head, Laboratory of Neurophysiology and Behavior, The Rockefeller University
Anne Brunet, Ph.D., Michele and Timothy Barakett Endowed Professor, Co-director of the Paul F. Glenn Laboratories for the Biology of Aging, Stanford University
Anne Brunet, Ph.D., Michele and Timothy Barakett Endowed professor, co-director of the Paul F. Glenn Laboratories for the Biology of Aging, Stanford University
A rich program of lectures and seminars featuring internal and external speakers help Rockefeller scientists keep abreast of their colleagues’ work and forge fruitful interdisciplinary collaborations.
After scouring more than 5,000 compounds, the Simon lab has identified several new classes of therapeutics that may help treat fibrolamellar carcinoma. #Rockefellerscience... See MoreSee Less
A Moment in the History of Biomedical Research: Flexner Hall is named for the Rockefeller Institute's first director, Simon Flexner. After an outbreak of spinal meningitis swept across New York City in 1904 and claimed 3,000 lives, Flexner began working on a cure. He eventually developed a serum to treat the deadly disease. A visionary physician scientist, Flexner was also among the first to propose that organ transplant would one day be possible. ... See MoreSee Less
After scouring more than 5,000 compounds, @sms10028 and colleagues have identified several new classes of therapeutics that may help treat fibrolamellar carcinoma. #RockefellerScience
https://t.co/uC7v9BNEFg
Our paper showing long lasting and continuously evolving antibody immunity one year after SARS-CoV-2 infection is out today in @Nature. Brought to you by the commitment of our fantastic study participants 👏@RockefellerUniv @NussenzweigL https://t.co/dBqbwRdBm5
Just published @Nature
Prior covid induces long-lasting humoral immunity for at least 1 year. Adding an mRNA vaccine provides markedly increased neutralizing antibody and memory B cells against the variants
https://t.co/EOyXFhsHEe
@NussenzweigL @RockefellerUniv
#LaskerLaureate Lyman C. Craig was born #OTD in 1906. He developed the countercurrent distribution technique as a method for the separation of biologically significant compounds. @RockefellerUniv https://t.co/FmvOZ9HeWf
